The general role for PPARγ in the regulation of lipidmetabolism is underlined by the therapeutic utilization of the PPARγ ligandsthiazolidinediones in obesity-linked type II diabetes [25]. The gene discussed is PPARG; the disease is type 2 diabetes mellitus.